Little House Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.63M	Buy	26,872 +3,198	+14%	+$186K	0.42%	57
2025 Q4	$1.28M	Sell	23,674 -2,645	-10%	-$127K	0.32%	66
2025 Q3	$1.19M	Buy	26,319 +1,291	+5%	+$60.3K	0.27%	74
2025 Q2	$1.16M	Buy	25,028 +6,009	+32%	+$295K	0.29%	75
2025 Q1	$1.16M	Buy	+19,019	New	+$1.11M	0.32%	72
2024 Q3	–	Sell	-5,341	Closed	-$222K	–	114
2024 Q2	$222K	Sell	5,341 -12,930	-71%	-$579K	0.07%	111
2024 Q1	$991K	Buy	18,271 +4,548	+33%	+$232K	0.33%	77
2023 Q4	$704K	Sell	13,723 -1,475	-10%	-$77.4K	0.26%	84
2023 Q3	$882K	Buy	15,198 +1,414	+10%	+$86.6K	0.36%	74
2023 Q2	$881K	Buy	13,784 +1,203	+10%	+$80.7K	0.37%	78
2023 Q1	$872K	Sell	12,581 -30	-0.2%	-$2.12K	0.41%	70
2022 Q4	$907K	Buy	12,611 +2,207	+21%	+$166K	0.45%	58
2022 Q3	$740K	Buy	10,404 +953	+10%	+$69.1K	0.39%	68
2022 Q2	$728K	Sell	9,451 -371	-4%	-$28.3K	0.39%	70
2022 Q1	$717K	Sell	9,822 -1,633	-14%	-$110K	0.37%	76
2021 Q4	$714K	Sell	11,455 -312	-3%	-$18.3K	0.38%	83
2021 Q3	$696K	Buy	11,767 +2,332	+25%	+$154K	0.41%	76
2021 Q2	$630K	Buy	+9,435	New	+$615K	0.34%	88
2021 Q1	–	Sell	-7,592	Closed	-$470K	–	110
2020 Q4	$470K	Buy	+7,592	New	+$467K	0.35%	70
2019 Q2	–	Sell	-1,261	Closed	-$60K	–	123
2019 Q1	$60K	Buy	+1,261	New	+$62.8K	0.05%	156